feed,title,long_url,short_url
Benzinga,Ipsen's Sohonos Scores Canadian Approval For Rare Connective Tissue Disease,https://benzinga.com/general/biotech/22/01/25179263/ipsens-sohonos-scores-canadian-approval-for-rare-connective-tissue-disease,https://bit.ly/32uK5Ei
Benzinga,FDA Approves Gilead's Remdesivir For Non-Hospitalized COVID-19 Patients At High Risk For Disease Progression,https://benzinga.com/general/biotech/22/01/25179130/fda-approves-gileads-remdesivir-for-non-hospitalized-covid-19-patients-at-high-risk-for-disease-p,https://bit.ly/3nTNxzB
